Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte–associated protein 4 therapy: A retrospective cohort study

[Figure: see text]

Detalles Bibliográficos
Autores principales: Naderi-Azad, Sheida, Sickandar, Faisal, Pezo, Rossanna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362262/
https://www.ncbi.nlm.nih.gov/pubmed/34409348
http://dx.doi.org/10.1016/j.jdin.2020.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362262/
https://www.ncbi.nlm.nih.gov/pubmed/34409348
http://dx.doi.org/10.1016/j.jdin.2020.10.005

Ejemplares similares